Cargando…

Co-existence of relapsing polychondritis and Crohn disease treated successfully with infliximab

Relapsing polychondritis (RP) is a rare, progressive immune-mediated systemic inflammatory disease of unknown etiology, characterized by recurrent inflammation of cartilaginous structures. Approximately 30% of RP cases are associated with other autoimmune diseases. However, the co-occurrence of RP a...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Hye-In, Kim, Hyun Jung, Kim, Ji-Min, Lee, Ju Yup, Park, Kyung Sik, Cho, Kwang Bum, Lee, Yoo Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yeungnam University College of Medicine 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787902/
https://www.ncbi.nlm.nih.gov/pubmed/32668525
http://dx.doi.org/10.12701/yujm.2020.00304
_version_ 1783632923633647616
author Jung, Hye-In
Kim, Hyun Jung
Kim, Ji-Min
Lee, Ju Yup
Park, Kyung Sik
Cho, Kwang Bum
Lee, Yoo Jin
author_facet Jung, Hye-In
Kim, Hyun Jung
Kim, Ji-Min
Lee, Ju Yup
Park, Kyung Sik
Cho, Kwang Bum
Lee, Yoo Jin
author_sort Jung, Hye-In
collection PubMed
description Relapsing polychondritis (RP) is a rare, progressive immune-mediated systemic inflammatory disease of unknown etiology, characterized by recurrent inflammation of cartilaginous structures. Approximately 30% of RP cases are associated with other autoimmune diseases. However, the co-occurrence of RP and Crohn disease (CD) has rarely been reported. Herein, we present a 35-year-old woman diagnosed with RP and CD, who was refractory to initial conventional medications, including azathioprine and glucocorticoid, but who subsequently responded to infliximab (IFX). For both diseases, remission was sustained with IFX. There has been no previous report regarding the successful treatment of co-existing RP and CD with IFX.
format Online
Article
Text
id pubmed-7787902
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Yeungnam University College of Medicine
record_format MEDLINE/PubMed
spelling pubmed-77879022021-01-14 Co-existence of relapsing polychondritis and Crohn disease treated successfully with infliximab Jung, Hye-In Kim, Hyun Jung Kim, Ji-Min Lee, Ju Yup Park, Kyung Sik Cho, Kwang Bum Lee, Yoo Jin Yeungnam Univ J Med Case Report Relapsing polychondritis (RP) is a rare, progressive immune-mediated systemic inflammatory disease of unknown etiology, characterized by recurrent inflammation of cartilaginous structures. Approximately 30% of RP cases are associated with other autoimmune diseases. However, the co-occurrence of RP and Crohn disease (CD) has rarely been reported. Herein, we present a 35-year-old woman diagnosed with RP and CD, who was refractory to initial conventional medications, including azathioprine and glucocorticoid, but who subsequently responded to infliximab (IFX). For both diseases, remission was sustained with IFX. There has been no previous report regarding the successful treatment of co-existing RP and CD with IFX. Yeungnam University College of Medicine 2020-06-19 /pmc/articles/PMC7787902/ /pubmed/32668525 http://dx.doi.org/10.12701/yujm.2020.00304 Text en Copyright © 2021 Yeungnam University College of Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Jung, Hye-In
Kim, Hyun Jung
Kim, Ji-Min
Lee, Ju Yup
Park, Kyung Sik
Cho, Kwang Bum
Lee, Yoo Jin
Co-existence of relapsing polychondritis and Crohn disease treated successfully with infliximab
title Co-existence of relapsing polychondritis and Crohn disease treated successfully with infliximab
title_full Co-existence of relapsing polychondritis and Crohn disease treated successfully with infliximab
title_fullStr Co-existence of relapsing polychondritis and Crohn disease treated successfully with infliximab
title_full_unstemmed Co-existence of relapsing polychondritis and Crohn disease treated successfully with infliximab
title_short Co-existence of relapsing polychondritis and Crohn disease treated successfully with infliximab
title_sort co-existence of relapsing polychondritis and crohn disease treated successfully with infliximab
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787902/
https://www.ncbi.nlm.nih.gov/pubmed/32668525
http://dx.doi.org/10.12701/yujm.2020.00304
work_keys_str_mv AT junghyein coexistenceofrelapsingpolychondritisandcrohndiseasetreatedsuccessfullywithinfliximab
AT kimhyunjung coexistenceofrelapsingpolychondritisandcrohndiseasetreatedsuccessfullywithinfliximab
AT kimjimin coexistenceofrelapsingpolychondritisandcrohndiseasetreatedsuccessfullywithinfliximab
AT leejuyup coexistenceofrelapsingpolychondritisandcrohndiseasetreatedsuccessfullywithinfliximab
AT parkkyungsik coexistenceofrelapsingpolychondritisandcrohndiseasetreatedsuccessfullywithinfliximab
AT chokwangbum coexistenceofrelapsingpolychondritisandcrohndiseasetreatedsuccessfullywithinfliximab
AT leeyoojin coexistenceofrelapsingpolychondritisandcrohndiseasetreatedsuccessfullywithinfliximab